BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31023019)

  • 1. Mitochondrial Processes in Targeted Cancer Therapy.
    Krejčíř R; Valík D; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):14-20. PubMed ID: 31023019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Membrane Proteins in the Treatment of Tumor Diseases and the Possibilities of Their Further Study.
    Dosedělová L; Nekulová M; Zahradníková M; Faktor J; Vojtěšek B; Hernychová L
    Klin Onkol; 2018; 31(Suppl 2):32-40. PubMed ID: 31023022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of HSF1 Protein in Malignant Transformation.
    Šimončík O; Pastorek M; Vojtěšek B; Müller P
    Klin Onkol; 2018; 31(Suppl 2):55-62. PubMed ID: 31023025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment.
    Skoupilová H; Michalová E; Hrstka R
    Klin Onkol; 2018; 31(Suppl 2):21-26. PubMed ID: 31023020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of HSP70 in Cancer and its Exploitation as a Therapeutic Target.
    Martinková V; Trčka F; Vojtěšek B; Müller P
    Klin Onkol; 2018; 31(Suppl 2):46-54. PubMed ID: 31023024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDM2 and HDMX Proteins in Human Cancer.
    Hároníková L; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):63-70. PubMed ID: 31023026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Significance of BRAFV600E Mutation in Thyroid Cancer in Terms of Novel Targeted Therapies - Overview of Current Knowledge and Studies.
    Iva J; Filip G; Martin B; Pavel Ž; Jan Č
    Klin Onkol; 2018; 31(5):339-344. PubMed ID: 30541319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of the Flavonoid Quercetin to Prevent and Treat Cancer - Current Status of Research.
    Jana N; Břetislav G; Pavel S; Pavla U
    Klin Onkol; 2018; 31(3):184-190. PubMed ID: 30441971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Role of PD-1/PD-L1 Signaling Pathway in Antitumor Immune Response].
    Zatloukalová P; Pjechová M; Babčanová S; Hupp TR; Vojtěšek B
    Klin Onkol; 2016; 29 Suppl 4(Suppl 4):72-77. PubMed ID: 27846724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant Tumors of the Penis - Dia-gnostics and Therapy.
    Mrinakova B; Ondrušová M; Švantnerová M; Ondruš D
    Klin Onkol; 2019; 32(1):31-39. PubMed ID: 30764627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of DNA Methylation on the Development of Cancer.
    Holčáková J
    Klin Onkol; 2018; 31(Suppl 2):41-45. PubMed ID: 31023023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiotherapy - Current Indications.
    Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
    Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prima-1 and APR-246 in Cancer Therapy.
    Zatloukalová P; Galoczová M; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):71-76. PubMed ID: 31023027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible Usage of p63 in Bioptic Diagnostics.
    Galoczová M; Nenutil R; Coates P; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer Cells as Dynamic System - Molecular and Phenotypic Changes During Tumor Formation, Progression and Dissemination].
    Sommerová L; Ondroušková E; Hrstka R
    Klin Onkol; 2016; 29 Suppl 4(Suppl 4):6-11. PubMed ID: 27846714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteogenomic Platform for Identification of Tumor Specific Antigens.
    Faktor J; Hernychová L; Vojtěšek B; Hupp T
    Klin Onkol; 2018; 31(Suppl 2):102-107. PubMed ID: 31023032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel Findings in Follicular Lymphoma Pathogenesis and the Concepts of Targeted Therapy].
    Deván J; Musilová K; Janíková A; Mráz M
    Klin Onkol; 2017; 30(4):247-257. PubMed ID: 28832170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Methods of microRNA Analysis.
    Bartošík M; Jiráková L
    Klin Onkol; 2018; 31(Suppl 2):93-101. PubMed ID: 31023031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.